Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Position Increased by Wells Fargo & Company MN
Wells Fargo & Company MN increased its holdings in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) by 54.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 17,458 shares of the company’s stock after buying an additional 6,131 shares during the period. Wells Fargo & Company MN’s […]
Wells Fargo & Company MN increased its holdings in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) by 54.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 17,458 shares of the company’s stock after buying an additional 6,131 shares during the period. Wells Fargo & Company MN’s […]
